Tandem peptides targeting HER2 for delivery of CD44 siRNA into HER2+breast cancer cells in vitro

被引：0
|
作者：
Kalogeros, James W.
Miserendino, Audreanna
Alexander-Bryant, Angela
Booth, Brian
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
基金：
美国国家科学基金会;
关键词：
D O I：
10.1158/1538-7445.AM2023-3979
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3979
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The Effect of HER2 Amplification in HER2+Breast Cancer
    Lee, M. K.
    Hurvitz, S. A.
    Tran, B. N.
    Fu, Y.
    Chung, D. U.
    Gornbein, J.
    Apple, S. K.
    Chang, H. R.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S45 - S45
  • [2] Clinicopathological analysis of CD44 expression in HER2 positive invasive breast cancer
    Sanaat, Z.
    Dolatkhah, R.
    Roosta, Y.
    Nikhanfar, A. R.
    Fakhrjou, A.
    BREAST, 2019, 44 : S25 - S26
  • [3] Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
    Inoue, Kazushi
    Fry, Elizabeth A.
    GENETICS & EPIGENETICS, 2015, 7 : 19 - 32
  • [4] Characterization of targeting peptide sequences for peptide-mediated delivery of siRNA in HER2+breast cancer
    Miserendino, Audreanna
    Tekle, Sevrina
    Kalogeros, James
    Alexander-Bryant, Angela
    CANCER RESEARCH, 2024, 84 (06)
  • [5] Multifunctional hybrid nanoparticles as magnetic delivery systems for siRNA targeting the HER2 gene in breast cancer cells
    Cristofolini, Tatiane
    Dalmina, Milene
    Sierra, Jelver A.
    Silva, Adny H.
    Pasa, Andre A.
    Pittella, Frederico
    Creczynski-Pasa, Tania B.
    MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2020, 109 (109):
  • [6] Targeted Nanoparticle for Co-delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis
    Ngamcherdtrakul, Worapol
    Bejan, Daniel S.
    Cruz-Munoz, William
    Reda, Moataz
    Zaidan, Husam Y.
    Siriwon, Natnaree
    Marshall, Suphalak
    Wang, Ruijie
    Nelson, Molly A.
    Rehwaldt, Justin P. C.
    Gray, Joe W.
    Hynynen, Kullervo
    Yantasee, Wassana
    SMALL, 2022, 18 (11)
  • [7] Developing therapeutic siRNA against HER2 in breast cancer cells
    Hu, Zhi
    Gu, Shenda
    Rantala, Juha
    Ngamcherdtrakul, Worapol
    Yantasee, Wassana
    Grays, Joe W.
    CANCER RESEARCH, 2012, 72
  • [8] HER2+breast cancer
    Hicks, David G.
    Kulkarni, Swati
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (02) : 263 - 273
  • [9] ARH460-16-2: A therapeutic monoclonal antibody targeting CD44 in Her2/neu negative breast cancer.
    Young, DS
    Sayegh, D
    Desousa-Hitzler, J
    Hahn, SE
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 193S - 193S
  • [10] High Level of CD44 Expression and Soluble CD44 Secretion Mediate Trastuzumab Resistance in HER2 Positive Breast Cancer.
    Jin, Q.
    Baek, J. M.
    Boulbes, D. R.
    Esteva, F. J.
    CANCER RESEARCH, 2011, 71
12345